The results showed that CD38 is a positive regulator of cardiac hypertrophy via inhibition of SIRT3–FOXO3 pathway and activation of Ca2+–calcineurin–NFAT signalling. This evidence concerns the gene SIRT3 and cardiac hypertrophy.